



A medical technology company developing a new wound therapy system, redefining the care of soft tissue wounds, requested The Aequitas Group to conduct a Health Technology Assessment (HTA) and health economic analysis to support both short- and long-term product growth. Along with helping to secure increased coverage and payment of the technology, the research team at The Aequitas Group enhanced market adoption and diffusion of the technology.
The evidence-based analyses provided by The Aequitas Group were used to support brand objectives with all major stakeholders, including the investment community. The review and analysis of the clinical findings and cost savings associated with use of the client’s product efficiently informed stakeholders about the economic value of the wound therapy system.
By providing an up to date evidence based technology assessment for use in modeling and marketing of, the client’s product to all stakeholders, the research team at The Aequitas Group was able to show comprehensive clinical and economic benefits to wound patients.
© 2009 The Aequitas Group, Inc. All Rights Reserved.